Trikafta
Payments companies reported to CMS as associated with Trikafta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trikafta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trikafta
These are the largest totals companies reported as associated with Trikafta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Carlos Milla | Palo Alto, CA | Pediatric Pulmonology | $13,250.99 |
| Kathleen Ramos | Seattle, WA | Pulmonary Disease | $10,039.83 |
| Jennifer Goralski | Chapel Hill, NC | Internal Medicine | $9,691.56 |
| Kate Powers | Albany, NY | Pediatrics | $6,295.00 |
| Christian Merlo | Baltimore, MD | Pulmonary Disease | $5,400.00 |
| Margaret Rosenfeld | Seattle, WA | Pediatric Pulmonology | $3,704.23 |
| Matthew Kreth | Chattanooga, TN | Pediatric Pulmonology | $3,600.63 |
| Gregory Sawicki | Boston, MA | Pediatric Pulmonology | $3,279.79 |
| Preeti Sharma | New Bedford, MA | Pediatrics | $2,522.30 |
| Rebecca Dezube | Baltimore, MD | Internal Medicine | $2,520.83 |
Prescribed Trikafta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.